Healthscope narrowly misses first strike
Healthscope has narrowly missed a first strike against its remuneration report.
Healthscope has narrowly missed a first strike against its remuneration report.
ASX aspirant Telix Pharmaceuticals has secured another high-profile backer.
BWX is seeking to raise $100 million in an underwritten renounceable rights issue via Goldman Sachs.
Fertility group Monash IVF is ensuring that if there is another round of industry consolidation on the way, then it's on the front foot.
Branded skin products manufacturer and marketer BWX Ltd is believed to be seeking to finalise about a $100 million equity funding package for a new acquisition.
Chief executive Paul Perreault says CSL has a range of exciting growth opportunities in front of it, including the new frontier of organ tra...
Doug Rathbone-backed Bio-Gene Technology launched its initial public offering on Wednesday, pricing the shares at 20ยข apiece.
Mr Perreault confirmed the net profit guidance at the annual meeting and said the company had a range of exciting growth opportunities in fr...
There's a strong argument for Australian men to be able to buy their potency drugs without a script.
One of the year's biggest investments in an Australian biotech is for one of medicine's great unsolved problems.
Enjoy unlimited access to Australia's best business news and market insights across desktop, tablet and mobile
Already a subscriber? Log in